NCT02386111 2018-07-26
A Study of Varlilumab (Anti-CD27) and Sunitinib in Patients With Metastatic Clear Cell Renal Cell Carcinoma
Celldex Therapeutics
Phase 1 Terminated
Celldex Therapeutics
M.D. Anderson Cancer Center
Medical University of South Carolina
AEterna Zentaris
Memorial Sloan Kettering Cancer Center